In a pilot study, 12 patients affected by high-risk/advanced stage hematologic malignancies and previously treated with multiple lines of chemotherapy, were transplanted with haplo-HSCT and received IL-10-DLI after myeloid engraftment (ALT-TEN trial). The gene discussed is IL10; the disease is hematologic disorder.